APA (7th ed.) Citation

D, M., A, H., V, G., F, I., & F, V. (2017). Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation. Frontiers in immunology, 8, 926. https://doi.org/10.3389/fimmu.2017.00926

Chicago Style (17th ed.) Citation

D, Meley, Héraud A, Gouilleux-Gruart V, Ivanes F, and Velge-Roussel F. "Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells Through Interleukin-6 Receptor Subunits Modulation." Frontiers in Immunology 8 (2017): 926. https://doi.org/10.3389/fimmu.2017.00926.

MLA (9th ed.) Citation

D, Meley, et al. "Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells Through Interleukin-6 Receptor Subunits Modulation." Frontiers in Immunology, vol. 8, 2017, p. 926, https://doi.org/10.3389/fimmu.2017.00926.